Pedro Manuel Campos Muelas

Title: Pedro Manuel Campos Muelas: Innovator in Medicinal Chemistry

Introduction

Pedro Manuel Campos Muelas is a prominent inventor based in Madrid, Spain. He has made significant contributions to the field of medicinal chemistry, particularly through his innovative patents. With a total of 2 patents, his work focuses on developing compounds that have potential therapeutic applications.

Latest Patents

One of his latest patents is related to tetrahydroisoquinoline compounds. This invention pertains to a novel class of tetrahydroisoquinoline compounds of formula I, along with compositions that include these compounds. The compounds and compositions can be utilized as medicaments in the treatment of cancer. Another significant patent involves drugs for inhibiting p38 and their uses. This invention describes compounds with a benzoxadiazolyl amine structure that can inhibit the activation or biological activity of p38 mitogen-activated protein kinase (MAPK). These compounds are particularly useful in treating diseases that can be alleviated by inhibiting p38 MAPK, such as inflammatory diseases or conditions presenting with pain.

Career Highlights

Throughout his career, Pedro has worked with notable organizations, including Allinky Biopharma and Universidad Autónoma de Madrid. His experience in these institutions has allowed him to further his research and development in medicinal chemistry.

Collaborations

Pedro has collaborated with esteemed colleagues, including Miguel Vega García and Esther Carrasco Romero. These partnerships have contributed to the advancement of his research and the successful development of his patents.

Conclusion

Pedro Manuel Campos Muelas is a distinguished inventor whose work in medicinal chemistry has the potential to impact the treatment of various diseases. His innovative patents reflect his commitment to advancing healthcare through scientific research.